US Covid-19: US FDA approves Pfizer's Paxlovid pill for at home treatment of Covid-19

Market news

22 December 2021

US Covid-19: US FDA approves Pfizer's Paxlovid pill for at home treatment of Covid-19

The US Food and Drug Administration on Wednesday authorised Pfizer's Paxlovid pill, the first anti-Covid-19 treatment pill to be authorised in the country. It will be used to treat high-risk patients with moderate to severe disease within five days of symptom onset. Pfizer said it was ready to commence delivery of the pill immediately.

Currencies. Daily history for Wednesday, December 22, 2021

Commodities. Daily history for Tuesday, December 21, 2021

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.